A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
Clinical trial NCT06556966 · COMPLETED
Trial details
- NCT number
- NCT06556966
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2025-02-13
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.